Tilt Investment Management Holdings, Pbc Bristol Myers Squibb CO Transaction History
Tilt Investment Management Holdings, Pbc
- $92.6 Billion
- Q4 2023
A detailed history of Tilt Investment Management Holdings, Pbc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Tilt Investment Management Holdings, Pbc holds 8,211 shares of BMY stock, worth $385,260. This represents 0.46% of its overall portfolio holdings.
Number of Shares
8,211
Previous 11,338
27.58%
Holding current value
$385,260
Previous $658 Million
35.98%
% of portfolio
0.46%
Previous 0.47%
Shares
3 transactions
Others Institutions Holding BMY
# of Institutions
2,810Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$8.98 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.44 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.07 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.45 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.12 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.8B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...